Reuters logo
BRIEF-Bafna Pharmaceuticals approves withdrawal of preferential issue of 4 mln share warrants
January 4, 2017 / 1:02 PM / a year ago

BRIEF-Bafna Pharmaceuticals approves withdrawal of preferential issue of 4 mln share warrants

Jan 4 (Reuters) - Bafna Pharmaceuticals Ltd :

* says approved withdrawal of preferential issue of 4 million earnings per share warrants Source text: (bit.ly/2j8E6wG) Further company coverage: (Bengaluru newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below